{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:52:29Z","timestamp":1787025149654,"version":"build-2736575974"},"reference-count":38,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug-induced reaction characterized by exanthema, eosinophilia and organ involvement. Patients reported sequelae comprising skin or organ alterations and autoimmune diseases. We investigated long-term complications of patients included in the German Registry of severe skin reactions between 2003 and 2023 with a definite or probable diagnosis of DRESS using a follow-up questionnaire. Cases were classified by severity (mild, moderate-to-severe) employing 2 scores (drug-induced liver injury [DILI] and acute kidney injury [AKI]). In total, 36\/61 questionnaires (59%) were analysed revealing an equal distribution: 18 mild and 18 moderate-to-severe cases. All patients experienced long-term complications. Skin disorders occurred in 81%, mucosal problems in 31% and hair\/nail complications in 43%. Severity groups were equally affected, whereas laboratory abnormalities appeared more often in moderate-to-severe cases. Haematological abnormalities were most frequently observed (94%), followed by elevated liver enzymes (88%) and impaired renal function parameters (31%). Alterations of HbA1c occurred in 16% and abnormal thyroid function in 19%, including 2 cases of Graves\u2019 disease. Intolerance reactions to other medication were observed in 27% of cases, explaining fear of further medication (51%) and resulting avoidance behaviour (49%).<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0310","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:58:00Z","timestamp":1782129480000},"source":"Crossref","is-referenced-by-count":1,"title":["\u201cDrug Reaction with Eosinophilia and Systemic Symptoms\u201d (DRESS): Long-term Outcomes Based on Severity \u2013 A Cohort Study"],"prefix":"10.2340","volume":"106","author":[{"given":"Anika","family":"Lipinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Paulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6596-1684","authenticated-orcid":false,"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"159580","doi-asserted-by":"crossref","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250\u2013257.","DOI":"10.1016\/S1085-5629(96)80038-1"},{"key":"159581","doi-asserted-by":"crossref","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013; 169: 1071\u20131080.","DOI":"10.1111\/bjd.12501"},{"key":"159582","doi-asserted-by":"crossref","unstructured":"Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010; 146: 1373\u20131379.","DOI":"10.1001\/archdermatol.2010.198"},{"key":"159583","doi-asserted-by":"crossref","unstructured":"Shiohara T, Kano Y, Takahashi R, Ishida T, Mizukawa Y. Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy 2012; 97: 122\u2013138.","DOI":"10.1159\/000335624"},{"key":"159584","doi-asserted-by":"crossref","unstructured":"Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol 2015; 29: 2199\u20132205.","DOI":"10.1111\/jdv.13212"},{"key":"159585","doi-asserted-by":"crossref","unstructured":"Lee JY, Lee SY, Hahm JE, Ha JW, Kim CW, Kim SS. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. Int J Dermatol 2017; 56: 944\u2013951.","DOI":"10.1111\/ijd.13667"},{"key":"159586","doi-asserted-by":"crossref","unstructured":"Saltzstein SL, Ackerman LV. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas. Cancer 1959; 12: 164\u2013182.","DOI":"10.1002\/1097-0142(195901\/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y"},{"key":"159587","doi-asserted-by":"crossref","unstructured":"Kano Y, Ishida T, Hirahara K, Shiohara T. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin N 2010; 94: 743\u2013759.","DOI":"10.1016\/j.mcna.2010.03.004"},{"key":"159588","doi-asserted-by":"crossref","unstructured":"Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol 2021; 77: 275\u2013289.","DOI":"10.1007\/s00228-020-03005-9"},{"key":"159589","doi-asserted-by":"crossref","unstructured":"Picard D, Janela B, Descamps V, D\u2019Incan M, Courville P, Jacquot S, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010; 2: 46ra62.","DOI":"10.1126\/scitranslmed.3001116"},{"key":"159590","doi-asserted-by":"crossref","unstructured":"Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113\u20131117.","DOI":"10.1001\/archderm.134.9.1113"},{"key":"159591","doi-asserted-by":"crossref","unstructured":"Descamps V. Drug reaction with eosinophilia and systemic symptoms and thyroiditis: human herpesvirus-6, the possible common link. Br J Dermatol 2013; 169: 952.","DOI":"10.1111\/bjd.12456"},{"key":"159592","doi-asserted-by":"crossref","unstructured":"Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083\u20131084.","DOI":"10.1111\/j.1365-2133.2007.07807.x"},{"key":"159593","doi-asserted-by":"crossref","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609\u2013611.","DOI":"10.1111\/j.1365-2133.2006.07704.x"},{"key":"159594","doi-asserted-by":"crossref","unstructured":"Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol 2013; 68: 721\u2013728.","DOI":"10.1016\/j.jaad.2012.10.017"},{"key":"159595","doi-asserted-by":"crossref","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 2011; 89: 806\u2013815.","DOI":"10.1038\/clpt.2011.58"},{"key":"159596","doi-asserted-by":"crossref","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120: c179\u201384.","DOI":"10.1159\/000339789"},{"key":"159597","doi-asserted-by":"crossref","unstructured":"Caba\u00f1as R, Ram\u00edrez E, Sendagorta E, Alamar R, Barranco R, Blanca-L\u00f3pez N, et al. Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome. J Investig Allergol Clin Immunol 2020; 30: 229\u2013253.","DOI":"10.18176\/jiaci.0480"},{"key":"159598","doi-asserted-by":"crossref","unstructured":"Huang YS, Wu CY, Chang TT, Peng CY, Lo GH, Hsu CW, et al. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: a nationwide study in Taiwan. Liver Int 2021; 41: 2671\u20132680.","DOI":"10.1111\/liv.14990"},{"key":"159599","doi-asserted-by":"crossref","unstructured":"Medina-C\u00e1liz I, Sanabria-Cabrera J, Villanueva-Paz M, Auk\u0161tikaln\u0117 L, Stephens C, Robles-D\u00edaz M, et al. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries. Arch Toxicol 2024; 98: 303\u2013325.","DOI":"10.1007\/s00204-023-03630-0"},{"key":"159600","doi-asserted-by":"crossref","unstructured":"Tharpe N. Adverse drug reactions in women\u2019s health care. J Midwife Womens Health 2011; 56: 205\u2013213.","DOI":"10.1111\/j.1542-2011.2010.00050.x"},{"key":"159601","doi-asserted-by":"crossref","unstructured":"Chiang PH, Ng CY, Kuo TT, Hui RCY, Chen CB, Lu CW, et al. Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome. J Dermatol 2021; 48: 92\u201395.","DOI":"10.1111\/1346-8138.15562"},{"key":"159602","doi-asserted-by":"crossref","unstructured":"Lili Y, Yi W, Ji Y, Yue S, Weimin S, Ming L. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS One 2012; 7: e37513.","DOI":"10.1371\/journal.pone.0037513"},{"key":"159603","doi-asserted-by":"crossref","unstructured":"Paulmann M, Mockenhaupt M. Schwere Hautreaktionen: klinisches Bild, Epidemiologie, \u00c4tiologie, Pathogenese und Therapie. Allergo J 2019; 28: 16\u201334.","DOI":"10.1007\/s15007-019-1973-z"},{"key":"159604","doi-asserted-by":"crossref","unstructured":"Lee JW, Yu DA, Cho S, Youn SW, Kwon O. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): a multicentric retrospective case series. J Dermatol 2023; 50: 814\u2013819.","DOI":"10.1111\/1346-8138.16715"},{"key":"159605","doi-asserted-by":"crossref","unstructured":"Iskandarli M, Ozturk G. Alopecia areata and vitiligo as a long-term sequelae of drug reaction with eosinophilia and systemic symptoms syndrome. Indian J Dermatol 2016; 61: 238.","DOI":"10.4103\/0019-5154.177781"},{"key":"159606","doi-asserted-by":"crossref","unstructured":"Allanore L, Roujeau JC. Clinic and pathogenesis of severe bullous skin reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis. In: Pichler WJ, editor. Drug Hypersensitivity. Basel: Karger; 2007: p. 267\u2013277. doi: 10.1159\/000104206.","DOI":"10.1159\/000104206"},{"key":"159607","doi-asserted-by":"crossref","unstructured":"Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, Beneton N, Jidar K, Barbaud A, et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. Eur J Dermatol 2010; 20: 68\u201373.","DOI":"10.1684\/ejd.2010.0821"},{"key":"159608","doi-asserted-by":"crossref","unstructured":"Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013; 168: 555\u2013562.","DOI":"10.1111\/bjd.12125"},{"key":"159609","doi-asserted-by":"crossref","unstructured":"Descamps V, Ben Sa\u00efd B, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, et al. Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 2010; 137: 703\u2013708.","DOI":"10.1016\/j.annder.2010.04.024"},{"key":"159610","doi-asserted-by":"crossref","unstructured":"Lee T, Lee YS, Yoon SY, Kim S, Bae YJ, Kwon HS, et al. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. J Am Acad Dermatol 2013; 69: 407\u2013415.","DOI":"10.1016\/j.jaad.2013.03.024"},{"key":"159611","doi-asserted-by":"crossref","unstructured":"Lin IC, Yang HC, Strong C, Yang CW, Cho YT, Chen KL, et al. Liver injury in patients with DRESS: a clinical study of 72 cases. J Am Acad Dermatol 2015; 72: 984\u2013991.","DOI":"10.1016\/j.jaad.2015.02.1130"},{"key":"159612","doi-asserted-by":"crossref","unstructured":"Dagnon da Silva M, Domingues SM, Oluic S, Radovanovic M, Kodela P, Nordin T, et al. Renal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of 71 cases. J Clin Med 2023; 12: 4576.","DOI":"10.3390\/jcm12144576"},{"key":"159613","doi-asserted-by":"crossref","unstructured":"Torroba Sanz B, Mendez Mart\u00ednez E, Cacho Asenjo E, Aquerreta Gonzalez I. Permanent renal sequelae secondary to drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by quetiapine. Eur J Hosp Pharm 2021; 28: 285\u2013288.","DOI":"10.1136\/ejhpharm-2019-002149"},{"key":"159614","doi-asserted-by":"crossref","unstructured":"Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol 2015; 42: 276\u2013282.","DOI":"10.1111\/1346-8138.12770"},{"key":"159615","doi-asserted-by":"crossref","unstructured":"Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol 2013; 68: 459\u2013465.","DOI":"10.1016\/j.jaad.2012.08.009"},{"key":"159616","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et al. Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab 2020; 34: 101387.","DOI":"10.1016\/j.beem.2020.101387"},{"key":"159617","doi-asserted-by":"crossref","unstructured":"Kano Y, Shiohara T. Long-term outcome of patients with severe cutaneous adverse reactions. Dermatol Sin 2013; 31: 211\u2013216.","DOI":"10.1016\/j.dsi.2013.09.004"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46366\/54423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46366\/54424","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46366\/54426","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46366\/54423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:58:52Z","timestamp":1782129532000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":38,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0310","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}